The dimension of preventable stroke in a large representative patient cohort
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received October 15, 2018
- Accepted in final form July 22, 2019
- First Published October 31, 2019.
Article Versions
- Previous version (October 31, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Christian Boehme, MD,
- Thomas Toell, MD,
- Lukas Mayer-Suess, MD,
- Lena Domig, MD,
- Raimund Pechlaner, PhD,
- Karin Willeit, PhD,
- Lena Tschiderer, BSc,
- Lisa Seekircher, BSc,
- Peter Willeit, PhD,
- Andrea Griesmacher, MD,
- Michael Knoflach, MD,
- Johann Willeit, MD and
- Stefan Kiechl, MD
- Christian Boehme, MD,
NONE
NONE
(1) EVER Pharma, funding for travel, (2) Amgen, funding for travel, (3) Medtronic, funding for travel, (4) Daiichi-Sankyo, funding for travel, (5) Bayer, funding for travel
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) VASCage (Centre for Promoting Vascular Health in the Ageing Community)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thomas Toell, MD,
NONE
NONE
Bayer, Pfizer
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lukas Mayer-Suess, MD,
NONE
NONE
(1) Bayer , travel grant, ESOC 2017 (2) Daiichi Sankyo , Speaker honoria, 2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lena Domig, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Raimund Pechlaner, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Karin Willeit, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lena Tschiderer, BSc,
NONE
NONE
(1) non-financial support from Sanofi outside the submitted work, funding for travel to conference
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
K-project grant from the Austrian Research Promotion Agency (ÂVASCageÂ, grant 843536), PhD student
NONE
Dr.-Johannes-and-Hertha-Tuba Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Lisa Seekircher, BSc,
NONE
NONE
non-financial support from Sanofi outside the submitted work, funding for travel to conference
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
K-project grant from the Austrian Research Promotion Agency (ÂVASCageÂ, grant 843536), Master student
NONE
Dr.-Johannes-and-Hertha-Tuba Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Peter Willeit, PhD,
NONE
NONE
Received support from Bayer, Daiichi Sankyo, and Sanofi for travelling and attending conferences.
NONE
Patent WO2017077016A1: MicroRNA-122 in metabolic diseases - A predictive diagnostic method for identifying whether a patient will develop metabolic syndrome and/or type-2 diabetes in the future.
NONE
NONE
Received consultancy fees from Novartis Pharmaceuticals.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Andrea Griesmacher, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michael Knoflach, MD,
NONE
NONE
(1) Daiichi Sankyō, Böhringer-Ingelheim, Sanofi-Aventis: Speakes's honoraria (2) Pfizer - travel grant (3) Austrian Stroke Society and European Stroke Organization - travel grant
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Austrian National Bank Anniversary Fund, #15644, PI, 2013 - 2017 (2) Austrian Research Promotion Agency FFG, #843536, Project leader, 2014-2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Johann Willeit, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stefan Kiechl, MD
NONE
NONE
NONE
Academic editor of PLOS One and Editorial Board Member Stroke
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I am the PI of the excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: ÂResearch Center of Excellence in Vascular Ageing  Tyrol, VASCage (K- Project No. 843536) funded by the BMVIT, BMWFW, Wirtschaftsagentur Wien and Standortagentur Tirol and of the K-Center VASCage (Center for Promoting Vascular Health in the Ageing Community, Austrian Research Promotion Agency) funded by the Austrian Ministry for Transport, Innovation and Technology, the Austrian Ministry for Digital and Economic Affairs and the federal states Tyrol, Salzburg and Vienna. .
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (C.B., T.T., L.M., L.D., R.P., K.W., L.T., L.S., P.W., M.K., J.W., S.K.), Medical University of Innsbruck, Austria; Department of Neurology (K.W.), Inselspital, University Hospital of Bern, Switzerland; Department of Public Health and Primary Care (P.W.), University of Cambridge, UK; and Central Institute for Medical and Chemical Laboratory Diagnosis (A.G.), Medical University of Innsbruck, Austria.
- Correspondence
Dr. Kiechl stefan.kiechl{at}i-med.ac.at or Dr. Willeit johann.willeit{at}i-med.ac.at
Article usage
Cited By...
Letters: Rapid online correspondence
- Author response: The dimension of preventable stroke in a large representative patient cohort
- Christian Boehme, Resident Neurologist, Department of Neurology, Medical University of Innsbruck
- Thomas Toell, Resident Neurologist, Department of Neurology, Medical University of Innsbruck
- Michael Knoflach, Neurologist, Department of Neurology, Medical University of Innsbruck
- Stefan Kiechl, Neurologist, Chair, Department of Neurology, Medical University of Innsbruck
Submitted June 24, 2020 - Author response: The dimension of preventable stroke in a large representative patient cohort
- Christian Boehme, Resident Neurologist, Department of Neurology, Medical University of Innsbruck
- Lukas Mayer, Resident Neurologist, Department of Neurology, Medical University of Innsbruck
- Johann Willeit, Neurologist, Department of Neurology, Medical University of Innsbruck
- Stefan Kiechl, Neurologist, Chair, Department of Neurology, Medical University of Innsbruck
Submitted June 24, 2020 - Reader Response: The dimension of preventable stroke in a large representative patient cohort
- Larry B. Goldstein, Ruth L Works Professor and Chair, Dept. of Neurology, University of Kentucky
Submitted December 16, 2019 - Reader response: The dimension of preventable stroke in a large representative patient cohort
- Dearbhla M. Kelly, Clinical Research Fellow, Wolfson Centre for the Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford
Submitted November 13, 2019
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan